{
  "disease_name": "Progressive myoclonic epilepsy type 3",
  "orpha_code": "263516",
  "processing_timestamp": "2025-07-16T08:16:23.780183",
  "run_number": 1,
  "analysis_type": "socioeconomic",
  "processing_duration": 38.4,
  "success": true,
  "error_details": null,
  "socioeconomic_analysis": {
    "orphacode": "263516",
    "disease_name": "Progressive myoclonic epilepsy type 3",
    "socioeconomic_impact_studies": [],
    "score": 0,
    "evidence_level": "Low evidence",
    "justification": "No disease-specific cost-of-illness or economic burden studies were identified for Progressive myoclonic epilepsy type 3 (ORPHA:263516) despite targeted searches of PubMed, Europe PMC, Google Scholar, and review of the Orphanet disease page citeturn1search0."
  }
}